KemPharm – Redesigning Approved Drugs For Better Efficacy And Safety
Peter Dazeley/The Image Bank via Getty Images
KemPharm, Inc. (KMPH) is a smallcap, commercial stage biotech company with a recently approved product Azstarys (‘KP415), a once-daily treatment indicated for attention deficit hyperactivity disorder (‘ADHD)…
